HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kennedy, J. C. Articles by Ekpaha-Mensah, J. A. Search for Related Content PubMed Articles by Kennedy, J. C. Articles by Ekpaha-Mensah, J. A.

Histoincompatibility Recognition Reaction by Irradiated or Mitomycin-Treated Parental Cells against Hybrid Spleen Cells Produces Hybrid Cell Proliferation and Illusion of Reaction of Hybrid against Parent¹

From the Division of Cancer Research of the Department of Pathology, Queen's University and the Kingston General Hospital, Kingston, Ontario, Canada

Abstract

The addition of heavily irradiated or mitomycin-treated spleen cells to cultures containing syngeneic spleen cells and foreign erythrocytes may stimulate to some extent the hemolytic plaque-forming cell responses of these cultures, but the addition of semi-allogeneic irradiated or mitomycin-treated spleen cells may cause much greater stimulation. This semi-allogeneic stimulation is completely reciprocal; the plaque-forming cell responses of F₁ hybrid spleen cell cultures often are stimulated as much after the addition of non-proliferating parental cells as are the responses of parental spleen cell cultures after the addition of non-proliferating F₁ hybrid cells. The possibility that an in vitro manifestation of hybrid resistance might be involved was ruled out. It was found that irradiated or mitomycin-treated cells, although unable to proliferate, were still able to initiate a recognition reaction against histoincompatible cells, releasing in the process a soluble factor which stimulated proliferation of cells of the antibody-forming series. The significance of this finding for "one-way" mixed lymphocyte reactions is discussed.

Footnotes

¹ This research was supported by grants from the National Cancer Institute of Canada.

² Research Associate of the National Cancer Institute of Canada.

³ Ghana Government Scholar.